Kristen Schreiber
Physician Assistant · Saint Louis, MONPI 1447748967
Payments from drug & device makers
Across 510 payments — averaging $27.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Johnson & Johnson$1K
- Dendreon Pharmaceuticals LLC$941
- Medtronic$933
- Sumitomo Pharma America, Inc.$917
- Ferring Pharmaceuticals Inc.$814
- plus $8K from 34 others
Across 2 payments — averaging $245.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$490
What the payments were for
- Travel & lodging$7786%
- Food & beverage$12,84092%
- Education$3753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $1,461 |
| Johnson & Johnson | 46 | $1,347 |
| Dendreon Pharmaceuticals LLC | 35 | $941 |
| Medtronic | 12 | $933 |
| Sumitomo Pharma America, Inc. | 57 | $917 |
| Ferring Pharmaceuticals Inc. | 26 | $814 |
| Bayer | 25 | $787 |
| AbbVie(2 entities) | 43 | $744 |
| Antares Pharma, Inc. | 56 | $648 |
| Convatec Inc. | 15 | $628 |
| Teleflex LLC | 9 | $599 |
| Astellas Pharma US Inc | 25 | $457 |
| Myriad Genetic Laboratories, Inc. | 11 | $451 |
| Urovant Sciences Inc | 25 | $363 |
| Urogen Pharma, Inc. | 11 | $268 |
| AstraZeneca | 9 | $266 |
| Amgen | 5 | $255 |
| Progenics Pharmaceuticals, Inc. | 8 | $255 |
| Novartis | 11 | $234 |
| SRS Medical Systems, Inc. | 3 | $229 |
| Procept Biorobotics Corporation | 3 | $207 |
| Blue Earth Diagnostics | 10 | $172 |
| Sun Pharmaceutical Industries Inc. | 7 | $130 |
| Merck | 6 | $126 |
| Exact Sciences | 1 | $125 |
| Pfizer | 7 | $123 |
| Tolmar, Inc. | 6 | $100 |
| Clarus Therapeutics Inc. | 6 | $84 |
| Accord Healthcare, Inc. | 5 | $76 |
| Olympus America Inc. | 2 | $50 |
| Tolmar Pharmaceuticals, Inc. | 2 | $34 |
| Rochester Medical Corporation | 2 | $31 |
| Endo USA, Inc. | 1 | $21 |
| 180 Medical, Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Myovant Sciences Inc. | 1 | $19 |
| Telix Pharmaceuticals | 1 | $18 |
| Halozyme Inc | 1 | $14 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,055
- INTERSTIM$621
- Xofigo$290
- Prolaris$279
- UroLift$274
- Nubeqa$266
- Erleada$261
- GEMTESA$250
- RYBREVANT$222
- CARVYKTI$222
- AquaBeam Robotic System$142
- ADSTILADRIN$134
- GENTLECATH$128
- AMS 700$126
- Cologuard Collection Kit$125
- XYOSTED$125
- FARXIGA$125
- UroLift System$122
- PYLARIFY$116
- BOTOX$115
How this compares
$13,993 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 733 | $598,755 |
| MyrbetriqMirabegron | 619 | $429,557 |
| Mirabegron ErMirabegron | 69 | $33,865 |
| Trospium Chloride ErTrospium Chloride | 148 | $26,589 |
| Methenamine Hippurate | 404 | $25,324 |
| Estradiol | 180 | $11,576 |
| Trospium Chloride | 194 | $7,711 |
| PremarinEstrogens, Conjugated | 14 | $6,420 |
| Solifenacin Succinate | 57 | $2,971 |
| YuvafemEstradiol | 16 | $1,905 |
| Oxybutynin Chloride ErOxybutynin Chloride | 103 | $1,533 |
| Cephalexin | 230 | $1,232 |
| Tamsulosin Hcl | 92 | $1,196 |
| Fosfomycin Tromethamine | 11 | $1,094 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 83 | $970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $917 | $598,755733 claims |
| Astellas Pharma US IncMyrbetriq | $457 | $429,557619 claims |
| PfizerPremarin | $123 | $6,42014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.
Other physician assistant in Saint Louis
- Kimberly BrownSaint Louis$28K
- Michael HesselSaint Louis$19K
- Erica WestbrooksSaint Louis$19K
- Christine EdwardsSaint Louis$18K
- Andrea MartinSaint Louis$17K
- Rachael HartkeSaint Louis$16K
- Jonathan PriceSaint Louis$10K
- Yongzhong WeiSaint Louis$9K
- Lisa RoelleSaint Louis$9K
- Alexa NaceancenoSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.